Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 173

1.

DNA methylation-based classification reveals difference between pediatric T-cell acute lymphoblastic leukemia and normal thymocytes.

Kimura S, Seki M, Kawai T, Goto H, Yoshida K, Isobe T, Sekiguchi M, Watanabe K, Kubota Y, Nannya Y, Ueno H, Shiozawa Y, Suzuki H, Shiraishi Y, Ohki K, Kato M, Koh K, Kobayashi R, Deguchi T, Hashii Y, Imamura T, Sato A, Kiyokawa N, Manabe A, Sanada M, Mansour MR, Ohara A, Horibe K, Kobayashi M, Oka A, Hayashi Y, Miyano S, Hata K, Ogawa S, Takita J.

Leukemia. 2019 Nov 15. doi: 10.1038/s41375-019-0626-2. [Epub ahead of print] No abstract available.

PMID:
31732719
2.

Acute myeloid leukemia with a cryptic NUP98/PRRX2 rearrangement developing after low-dose methotrexate therapy for rheumatoid arthritis.

Chonabayashi K, Yoshida Y, Kitawaki T, Nannya Y, Nakamura M, Oshima S, Hishizawa M, Yamashita K, Ogawa S, Takaori-Kondo A.

Ann Hematol. 2019 Nov 14. doi: 10.1007/s00277-019-03838-0. [Epub ahead of print] No abstract available.

PMID:
31728617
3.

Novel DDX41 variants in Thai patients with myeloid neoplasms.

Polprasert C, Takeda J, Niparuck P, Rattanathammethee T, Pirunsarn A, Suksusut A, Kobbuaklee S, Wudhikarn K, Lawasut P, Kongkiatkamon S, Chuncharunee S, Songserm K, Phowthongkum P, Bunworasate U, Nannya Y, Yoshida K, Makishima H, Ogawa S, Rojnuckarin P.

Int J Hematol. 2019 Nov 11. doi: 10.1007/s12185-019-02770-3. [Epub ahead of print]

PMID:
31713024
4.

Predisposed genomic instability in pre-treatment bone marrow evolves to therapy-related myeloid neoplasms in malignant lymphoma.

Katagiri S, Makishima H, Azuma K, Nannya Y, Saitoh Y, Yoshizawa S, Akahane D, Fujimoto H, Ito Y, Velaga R, Umezu T, Ohyashiki JH, Ogawa S, Ohyashiki K.

Haematologica. 2019 Nov 7. pii: haematol.2019.229856. doi: 10.3324/haematol.2019.229856. [Epub ahead of print]

5.

RNAmut: robust identification of somatic mutations in acute myeloid leukemia using RNA-seq.

Gu M, Zwiebel M, Ong SH, Boughton N, Nomdedeu J, Basheer F, Nannya Y, Quiros PM, Ogawa S, Cazzola M, Rad R, Butler AP, Vijayabaskar MS, Vassiliou G.

Haematologica. 2019 Oct 24. pii: haematol.2019.230821. doi: 10.3324/haematol.2019.230821. [Epub ahead of print]

6.

Persistent clonal cytogenetic abnormality with del(20q) from an initial diagnosis of acute promyelocytic leukemia.

Fujioka M, Itonaga H, Kato T, Nannya Y, Hashimoto M, Kasai S, Toriyama E, Kamijo R, Taguchi M, Taniguchi H, Sato S, Atogami S, Imaizumi Y, Hata T, Moriuchi Y, Ogawa S, Miyazaki Y.

Int J Hematol. 2019 Sep 12. doi: 10.1007/s12185-019-02731-w. [Epub ahead of print]

PMID:
31515708
7.

Genome analysis of myelodysplastic syndromes among atomic bomb survivors in Nagasaki.

Taguchi M, Mishima H, Shiozawa Y, Hayashida C, Kinoshita A, Nannya Y, Makishima H, Horai M, Matsuo M, Sato S, Itonaga H, Kato T, Taniguchi H, Imanishi D, Imaizumi Y, Hata T, Takenaka M, Moriuchi Y, Shiraishi Y, Miyano S, Ogawa S, Yoshiura KI, Miyazaki Y.

Haematologica. 2019 May 17. pii: haematol.2019.219386. doi: 10.3324/haematol.2019.219386. [Epub ahead of print]

8.

Usage Patterns of GlucoNote, a Self-Management Smartphone App, Based on ResearchKit for Patients With Type 2 Diabetes and Prediabetes.

Yamaguchi S, Waki K, Nannya Y, Nangaku M, Kadowaki T, Ohe K.

JMIR Mhealth Uhealth. 2019 Apr 24;7(4):e13204. doi: 10.2196/13204.

9.

Frequent germline mutations of HAVCR2 in sporadic subcutaneous panniculitis-like T-cell lymphoma.

Polprasert C, Takeuchi Y, Kakiuchi N, Yoshida K, Assanasen T, Sitthi W, Bunworasate U, Pirunsarn A, Wudhikarn K, Lawasut P, Uaprasert N, Kongkiatkamon S, Moonla C, Sanada M, Akita N, Takeda J, Fujii Y, Suzuki H, Nannya Y, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Rojnuckarin P, Ogawa S, Makishima H.

Blood Adv. 2019 Feb 26;3(4):588-595. doi: 10.1182/bloodadvances.2018028340.

10.

A germline HLTF mutation in familial MDS induces DNA damage accumulation through impaired PCNA polyubiquitination.

Takaoka K, Kawazu M, Koya J, Yoshimi A, Masamoto Y, Maki H, Toya T, Kobayashi T, Nannya Y, Arai S, Ueno T, Ueno H, Suzuki K, Harada H, Manabe A, Hayashi Y, Mano H, Kurokawa M.

Leukemia. 2019 Jul;33(7):1773-1782. doi: 10.1038/s41375-019-0385-0. Epub 2019 Jan 29.

PMID:
30696947
11.

Prominence of nestin-expressing Schwann cells in bone marrow of patients with myelodysplastic syndromes with severe fibrosis.

Cao-Sy L, Obara N, Sakamoto T, Kato T, Hattori K, Sakashita S, Nannya Y, Ogawa S, Harada H, Sakata-Yanagimoto M, Nishikii H, Chiba S.

Int J Hematol. 2019 Mar;109(3):309-318. doi: 10.1007/s12185-018-02576-9. Epub 2019 Jan 10.

PMID:
30632058
12.

Age-related remodelling of oesophageal epithelia by mutated cancer drivers.

Yokoyama A, Kakiuchi N, Yoshizato T, Nannya Y, Suzuki H, Takeuchi Y, Shiozawa Y, Sato Y, Aoki K, Kim SK, Fujii Y, Yoshida K, Kataoka K, Nakagawa MM, Inoue Y, Hirano T, Shiraishi Y, Chiba K, Tanaka H, Sanada M, Nishikawa Y, Amanuma Y, Ohashi S, Aoyama I, Horimatsu T, Miyamoto S, Tsunoda S, Sakai Y, Narahara M, Brown JB, Sato Y, Sawada G, Mimori K, Minamiguchi S, Haga H, Seno H, Miyano S, Makishima H, Muto M, Ogawa S.

Nature. 2019 Jan;565(7739):312-317. doi: 10.1038/s41586-018-0811-x. Epub 2019 Jan 2.

PMID:
30602793
13.

Recurrent CCND3 mutations in MLL-rearranged acute myeloid leukemia.

Matsuo H, Yoshida K, Fukumura K, Nakatani K, Noguchi Y, Takasaki S, Noura M, Shiozawa Y, Shiraishi Y, Chiba K, Tanaka H, Okada A, Nannya Y, Takeda J, Ueno H, Shiba N, Yamato G, Handa H, Ono Y, Hiramoto N, Ishikawa T, Usuki K, Ishiyama K, Miyawaki S, Itonaga H, Miyazaki Y, Kawamura M, Yamaguchi H, Kiyokawa N, Tomizawa D, Taga T, Tawa A, Hayashi Y, Mano H, Miyano S, Kamikubo Y, Ogawa S, Adachi S.

Blood Adv. 2018 Nov 13;2(21):2879-2889. doi: 10.1182/bloodadvances.2018019398.

14.

[Novel therapies for higher-risk myelodysplastic syndromes].

Nannya Y.

Rinsho Ketsueki. 2018;59(10):2058-2066. doi: 10.11406/rinketsu.59.2058. Review. Japanese.

PMID:
30305509
15.

Infection perturbs Bach2- and Bach1-dependent erythroid lineage 'choice' to cause anemia.

Kato H, Itoh-Nakadai A, Matsumoto M, Ishii Y, Watanabe-Matsui M, Ikeda M, Ebina-Shibuya R, Sato Y, Kobayashi M, Nishizawa H, Suzuki K, Muto A, Fujiwara T, Nannya Y, Malcovati L, Cazzola M, Ogawa S, Harigae H, Igarashi K.

Nat Immunol. 2018 Oct;19(10):1059-1070. doi: 10.1038/s41590-018-0202-3. Epub 2018 Sep 24.

PMID:
30250186
16.

Molecular pathogenesis of disease progression in MLL-rearranged AML.

Kotani S, Yoda A, Kon A, Kataoka K, Ochi Y, Shiozawa Y, Hirsch C, Takeda J, Ueno H, Yoshizato T, Yoshida K, Nakagawa MM, Nannya Y, Kakiuchi N, Yamauchi T, Aoki K, Shiraishi Y, Miyano S, Maeda T, Maciejewski JP, Takaori-Kondo A, Ogawa S, Makishima H.

Leukemia. 2019 Mar;33(3):612-624. doi: 10.1038/s41375-018-0253-3. Epub 2018 Sep 12.

17.

Prognostic factors of Erdheim-Chester disease: a nationwide survey in Japan.

Toya T, Ogura M, Toyama K, Yoshimi A, Shinozaki-Ushiku A, Honda A, Honda K, Hosoya N, Murakami Y, Kawashima H, Nannya Y, Arai S, Nakamura F, Shinoda Y, Nangaku M, Miyagawa K, Fukayama M, Moriya-Saito A, Katayama I, Ogura T, Kurokawa M.

Haematologica. 2018 Nov;103(11):1815-1824. doi: 10.3324/haematol.2018.190728. Epub 2018 Jul 5.

18.

R-THP-COP versus R-CHOP in patients younger than 70 years with untreated diffuse large B cell lymphoma: A randomized, open-label, noninferiority phase 3 trial.

Hara T, Yoshikawa T, Goto H, Sawada M, Yamada T, Fukuno K, Kasahara S, Shibata Y, Matsumoto T, Mabuchi R, Nakamura N, Nakamura H, Ninomiya S, Kitagawa J, Kanemura N, Nannya Y, Katsumura N, Takahashi T, Kito Y, Takami T, Miyazaki T, Takeuchi T, Shimizu M, Tsurumi H.

Hematol Oncol. 2018 Oct;36(4):638-644. doi: 10.1002/hon.2524. Epub 2018 Jun 8.

PMID:
29882279
19.

Blastic plasmacytoid dendritic cell neoplasm arising from clonal hematopoiesis.

Suma S, Sakata-Yanagimoto M, Nguyen TB, Hattori K, Sato T, Noguchi M, Nannya Y, Ogawa S, Watanabe R, Fujimoto M, Nakamura N, Kusakabe M, Nishikii H, Kato T, Chiba S.

Int J Hematol. 2018 Oct;108(4):447-451. doi: 10.1007/s12185-018-2461-z. Epub 2018 Apr 28.

PMID:
29705980
20.

[Relationship between clinical features and somatic gene mutations in myelodysplastic syndrome].

Hirasawa N, Sakata-Yanagimoto M, Nannya Y, Hattori K, Suehara Y, Kato T, Yokoyama Y, Kurita N, Obara N, Ogawa S, Hasegawa Y, Chiba S.

Rinsho Ketsueki. 2018;59(1):80-83. doi: 10.11406/rinketsu.59.80. Japanese.

PMID:
29415943
21.

Progression to polythythemia vera from familial thrombocytosis with germline JAK2 R867Q mutation.

Maie K, Yokoyama Y, Yano Y, Kato T, Nannya Y, Ogawa S, Noguchi M, Sakata-Yanagimoto M, Chiba S.

Ann Hematol. 2018 Apr;97(4):737-739. doi: 10.1007/s00277-017-3209-1. Epub 2018 Jan 24. No abstract available.

PMID:
29368262
22.

Nonmyelomatous Ascites Resulting from the Increased Secretion of Vascular Endothelial Growth Factor in Multiple Myeloma.

Maki H, Nannya Y, Imai Y, Yamaguchi S, Kamikubo Y, Ichikawa M, Nakamura F, Kurokawa M.

Intern Med. 2018 Mar 1;57(5):725-727. doi: 10.2169/internalmedicine.8886-17. Epub 2017 Nov 20.

23.

Physiological Srsf2 P95H expression causes impaired hematopoietic stem cell functions and aberrant RNA splicing in mice.

Kon A, Yamazaki S, Nannya Y, Kataoka K, Ota Y, Nakagawa MM, Yoshida K, Shiozawa Y, Morita M, Yoshizato T, Sanada M, Nakayama M, Koseki H, Nakauchi H, Ogawa S.

Blood. 2018 Feb 8;131(6):621-635. doi: 10.1182/blood-2017-01-762393. Epub 2017 Nov 16.

24.

A novel genetic and morphologic phenotype of ARID2-mediated myelodysplasia.

Sakai H, Hosono N, Nakazawa H, Przychodzen B, Polprasert C, Carraway HE, Sekeres MA, Radivoyevitch T, Yoshida K, Sanada M, Yoshizato T, Kataoka K, Nakagawa MM, Ueno H, Nannya Y, Kon A, Shiozawa Y, Takeda J, Shiraishi Y, Chiba K, Miyano S, Singh J, Padgett RA, Ogawa S, Maciejewski JP, Makishima H.

Leukemia. 2018 Mar;32(3):839-843. doi: 10.1038/leu.2017.319. Epub 2017 Nov 3. No abstract available.

PMID:
29099495
25.

A nationwide survey of hypoplastic myelodysplastic syndrome (a multicenter retrospective study).

Kobayashi T, Nannya Y, Ichikawa M, Oritani K, Kanakura Y, Tomita A, Kiyoi H, Kobune M, Kato J, Kawabata H, Shindo M, Torimoto Y, Yonemura Y, Hanaoka N, Nakakuma H, Hasegawa D, Manabe A, Fujishima N, Fujii N, Tanimoto M, Morita Y, Matsuda A, Fujieda A, Katayama N, Ohashi H, Nagai H, Terada Y, Hino M, Sato K, Obara N, Chiba S, Usuki K, Ohta M, Imataki O, Uemura M, Takaku T, Komatsu N, Kitanaka A, Shimoda K, Watanabe K, Tohyama K, Takaori-Kondo A, Harigae H, Arai S, Miyazaki Y, Ozawa K, Kurokawa M; for National Research Group on Idiopathic Bone Marrow Failure Syndromes.

Am J Hematol. 2017 Dec;92(12):1324-1332. doi: 10.1002/ajh.24905. Epub 2017 Sep 28.

26.

Toll-like receptor genetic variations in bone marrow transplantation.

Uchino K, Mizuno S, Sato-Otsubo A, Nannya Y, Mizutani M, Horio T, Hanamura I, Espinoza JL, Onizuka M, Kashiwase K, Morishima Y, Fukuda T, Kodera Y, Doki N, Miyamura K, Mori T, Ogawa S, Takami A.

Oncotarget. 2017 Jul 11;8(28):45670-45686. doi: 10.18632/oncotarget.17315.

27.

Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantation.

Yoshizato T, Nannya Y, Atsuta Y, Shiozawa Y, Iijima-Yamashita Y, Yoshida K, Shiraishi Y, Suzuki H, Nagata Y, Sato Y, Kakiuchi N, Matsuo K, Onizuka M, Kataoka K, Chiba K, Tanaka H, Ueno H, Nakagawa MM, Przychodzen B, Haferlach C, Kern W, Aoki K, Itonaga H, Kanda Y, Sekeres MA, Maciejewski JP, Haferlach T, Miyazaki Y, Horibe K, Sanada M, Miyano S, Makishima H, Ogawa S.

Blood. 2017 Apr 27;129(17):2347-2358. doi: 10.1182/blood-2016-12-754796. Epub 2017 Feb 21.

28.

Late Reactivation of Hepatitis B Virus after Chemotherapies for Hematological Malignancies: A Case Report and Review of the Literature.

Yamada T, Nannya Y, Suetsugu A, Shimizu S, Sugihara J, Shimizu M, Seishima M, Tsurumi H.

Intern Med. 2017;56(1):115-118. doi: 10.2169/internalmedicine.56.7468. Epub 2017 Jan 1.

29.

Previous dropout from diabetic care as a predictor of patients' willingness to use mobile applications for self-management: A cross-sectional study.

Yamaguchi S, Waki K, Tomizawa N, Waki H, Nannya Y, Nangaku M, Kadowaki T, Ohe K.

J Diabetes Investig. 2017 Jul;8(4):542-549. doi: 10.1111/jdi.12613. Epub 2017 Feb 22.

30.

Symptomatic Acute Pancreatitis Induced by Nilotinib: A Report of Two Cases.

Yamada T, Nannya Y, Shimizu M, Seishima M, Tsurumi H.

Intern Med. 2016;55(23):3495-3497. Epub 2016 Dec 1.

31.

[Evaluation of Immature Platelet Fraction Measurements Using an Automated Hematology Analyzer, Sysmex XN].

Yoshikawa N, Masuda A, Jona M, Okubo S, Nannya Y, Yokota H, Kurokawa M, Yatomi Y.

Rinsho Byori. 2016 Nov;64(11):1220-1228. Japanese.

PMID:
30695302
32.

Progress in the diagnosis of and therapy for MDS.

Nannya Y.

Rinsho Ketsueki. 2016;57(10):1980-1990. Japanese.

PMID:
27725596
33.

Comparison of graft-versus-host disease-free, relapse-free survival according to a variety of graft sources: antithymocyte globulin and single cord blood provide favorable outcomes in some subgroups.

Inamoto Y, Kimura F, Kanda J, Sugita J, Ikegame K, Nakasone H, Nannya Y, Uchida N, Fukuda T, Yoshioka K, Ozawa Y, Kawano I, Atsuta Y, Kato K, Ichinohe T, Inoue M, Teshima T; JSHCT GVHD Working Group.

Haematologica. 2016 Dec;101(12):1592-1602. Epub 2016 Aug 4.

34.

Serum concentrations of l-kynurenine predict clinical outcomes of patients with peripheral T-cell lymphoma, not otherwise specified.

Shibata Y, Hara T, Matsumoto T, Nakamura N, Nakamura H, Ninomiya S, Kitagawa J, Goto N, Nannya Y, Ito H, Kito Y, Miyazaki T, Takeuchi T, Saito K, Seishima M, Takami T, Moriwaki H, Shimizu M, Tsurumi H.

Hematol Oncol. 2017 Dec;35(4):637-644. doi: 10.1002/hon.2318. Epub 2016 Jun 24.

PMID:
27338762
35.

Efficacy and safety of denosumab in multiple myeloma.

Kitagawa J, Shibata Y, Matsumoto T, Nakamura N, Nakamura H, Ninomiya S, Nannya Y, Hara T, Tsurumi H.

Rinsho Ketsueki. 2016 May;57(5):592-6. doi: 10.11406/rinketsu.57.592. Japanese.

PMID:
27263783
36.

Utility of voriconazole therapeutic drug monitoring: a meta-analysis.

Luong ML, Al-Dabbagh M, Groll AH, Racil Z, Nannya Y, Mitsani D, Husain S.

J Antimicrob Chemother. 2016 Jul;71(7):1786-99. doi: 10.1093/jac/dkw099. Epub 2016 May 10.

PMID:
27165788
37.

Prognostic significance of Wilms tumor 1 mRNA expression levels in peripheral blood and bone marrow in patients with myelodysplastic syndromes.

Kobayashi S, Ueda Y, Nannya Y, Shibayama H, Tamura H, Ogata K, Akatsuka Y, Usuki K, Ito Y, Okada M, Suzuki T, Hata T, Matsuda A, Tohyama K, Kakumoto K, Koga D, Mitani K, Naoe T, Sugiyama H, Takaku F.

Cancer Biomark. 2016 Mar 31;17(1):21-32. doi: 10.3233/CBM-160612.

PMID:
27062571
38.

Multiple myeloma with Russell bodies and needle-shaped crystalline inclusions.

Yamada T, Nannya Y, Mita N, Shimizu M, Seishima M, Tsurumi H.

Int J Hematol. 2016 May;103(5):483-5. doi: 10.1007/s12185-016-1985-3. Epub 2016 Mar 16. No abstract available.

PMID:
26984592
39.

Spectrum of clinical and genetic features of patients with inherited platelet disorder with suspected predisposition to hematological malignancies: a nationwide survey in Japan.

Yoshimi A, Toya T, Nannya Y, Takaoka K, Kirito K, Ito E, Nakajima H, Hayashi Y, Takahashi T, Moriya-Saito A, Suzuki K, Harada H, Komatsu N, Usuki K, Ichikawa M, Kurokawa M.

Ann Oncol. 2016 May;27(5):887-95. doi: 10.1093/annonc/mdw066. Epub 2016 Feb 15.

PMID:
26884589
40.

Prognostic value of the combination of serum l-kynurenine level and indoleamine 2,3-dioxygenase mRNA expression in acute myeloid leukemia.

Hara T, Matsumoto T, Shibata Y, Nakamura N, Nakamura H, Ninomiya S, Kitagawa J, Nannya Y, Shimizu M, Ito H, Saito K, Tsurumi H.

Leuk Lymphoma. 2016 Sep;57(9):2208-11. doi: 10.3109/10428194.2015.1128541. Epub 2016 Jan 13. No abstract available.

PMID:
26762931
41.

Efficacy of rituximab maintenance therapy for aggressive B-cell lymphoma depends on use of rituximab in induction therapy: a meta-analysis of randomized controlled trials.

Nannya Y, Goto N, Shimizu M, Seishima M, Tsurumi H.

Haematologica. 2015 Dec;100(12):e519-20. doi: 10.3324/haematol.2015.136622. Review. No abstract available.

42.

Acute pericarditis before engraftment in hematopoietic stem cell transplantation.

Shinohara A, Honda A, Nukina A, Takaoka K, Tsukamoto A, Hangai S, Kogure Y, Kobayashi T, Yamazaki S, Ueda K, Nakamura F, Nannya Y, Kurokawa M.

Bone Marrow Transplant. 2016 Mar;51(3):459-61. doi: 10.1038/bmt.2015.282. Epub 2015 Nov 23. No abstract available.

PMID:
26595074
43.

Incidentally-detected t(9;22)(q34;q11)/BCR-ABL1- positive clone developing into chronic phase chronic myeloid leukaemia after four years of dormancy.

Morita K, Nakamura F, Taoka K, Satoh Y, Iizuka H, Masuda A, Seo S, Nannya Y, Yatomi Y, Kurokawa M.

Br J Haematol. 2016 Sep;174(5):815-7. doi: 10.1111/bjh.13804. Epub 2015 Nov 12. No abstract available.

PMID:
26560179
44.

Clinical usefulness of WT1 mRNA expression in bone marrow detected by a new WT1 mRNA assay kit for monitoring acute myeloid leukemia: a comparison with expression of WT1 mRNA in peripheral blood.

Kitamura K, Nishiyama T, Ishiyama K, Miyawaki S, Miyazaki K, Suzuki K, Masaie H, Okada M, Ogawa H, Imai K, Kiyoi H, Naoe T, Yokoyama Y, Chiba S, Hata T, Miyazaki Y, Hatta Y, Takeuchi J, Nannya Y, Kurokawa M, Ueda Y, Koga D, Sugiyama H, Takaku F.

Int J Hematol. 2016 Jan;103(1):53-62. doi: 10.1007/s12185-015-1882-1. Epub 2015 Oct 31.

PMID:
26520650
45.

Genome-wide surveillance of mismatched alleles for graft-versus-host disease in stem cell transplantation.

Sato-Otsubo A, Nannya Y, Kashiwase K, Onizuka M, Azuma F, Akatsuka Y, Ogino Y, Satake M, Sanada M, Chiba S, Saji H, Inoko H, Kennedy GC, Yamamoto K, Morishima S, Morishima Y, Kodera Y, Sasazuki T, Ogawa S; Japan Marrow Donor Program.

Blood. 2015 Dec 17;126(25):2752-63. doi: 10.1182/blood-2015-03-630707. Epub 2015 Oct 2.

PMID:
26432889
46.

Prognostic relevance of CD20 expression in peripheral T-cell lymphomas: a multi-center retrospective study.

Toya T, Nannya Y, Hangaishi A, Shiseki M, Shimoyama T, Sakamaki H, Motoji T, Usuki K, Nakamura F, Kurokawa M.

Leuk Lymphoma. 2016;57(4):961-4. doi: 10.3109/10428194.2015.1083097. Epub 2015 Dec 23. No abstract available.

PMID:
26366623
47.

Successful Control of Carcinoma of Unknown Primary with Axitinib, a Novel Molecular-Targeted Agent: A Case Report.

Honda A, Yoshimi A, Ushiku T, Shinoda Y, Kawano H, Toya T, Kogure Y, Yamashita H, Kume H, Nannya Y, Kurokawa M.

Chemotherapy. 2014;60(5-6):342-5. doi: 10.1159/000437135. Epub 2015 Aug 18.

PMID:
26288144
48.

Primary Retroperitoneal Tumor with Unexpected Gingival Involvement.

Otsuka M, Nagata M, Suzuki M, Nannya Y, Ota S, Tanimoto T, Kume H, Kurokawa M, Homma Y.

Intern Med. 2015;54(14):1787-90. doi: 10.2169/internalmedicine.54.3839. Epub 2015 Jul 15.

49.

Comparison of garenoxacin with levofloxacin as antimicrobial prophylaxis in acute myeloid leukemia.

Uni M, Yoshimi A, Yamazaki S, Taoka K, Shinohara A, Nannya Y, Nakamura F, Kurokawa M.

Jpn J Clin Oncol. 2015 Aug;45(8):745-8. doi: 10.1093/jjco/hyv071. Epub 2015 May 19.

PMID:
25989991
50.

The criteria to suspect chronic myeloid leukemia using absolute basophil counts in peripheral blood.

Masuda A, Jona M, Satoh Y, Terashima M, Shimosaka H, Nannya Y, Yokota H, Kurokawa M, Yatomi Y.

Int J Hematol. 2015 Jun;101(6):626-8. doi: 10.1007/s12185-015-1777-1. Epub 2015 Mar 12. No abstract available.

PMID:
25762202

Supplemental Content

Loading ...
Support Center